CytexOrtho
CytexOrtho is a pioneering company in orthopedic joint preservation, focusing on developing cartilage resurfacing technology aimed at younger patients suffering from osteoarthritis. Their mission is to innovate in regenerative medicine and provide solutions to avoid or delay joint replacement surgeries, especially targeting the age group of 14-55. The company is actively involved in clinical trials and is advancing a technology that aims to regrow cartilage to repair joints, with a vision to transform the treatment landscape for osteoarthritis.
Industries
Nr. of Employees
small (1-50)
CytexOrtho
Durham, North Carolina, United States, North America
Patents
Products
Hip cartilage resurfacing implant (in development)
An investigational implant designed to resurface hip joint cartilage and promote cartilage regrowth as a joint-preserving alternative for patients with early osteoarthritis; described as in development and not yet commercially available or approved.
Hip cartilage resurfacing implant (in development)
An investigational implant designed to resurface hip joint cartilage and promote cartilage regrowth as a joint-preserving alternative for patients with early osteoarthritis; described as in development and not yet commercially available or approved.
Services
Sponsorship and operational preparation to move investigational hip implant devices into human clinical trials, including obtaining requisite regulatory permissions.
Research and development services to design, evaluate, and prepare implantable cartilage-regeneration devices for regulatory submission and clinical testing.
Sponsorship and operational preparation to move investigational hip implant devices into human clinical trials, including obtaining requisite regulatory permissions.
Research and development services to design, evaluate, and prepare implantable cartilage-regeneration devices for regulatory submission and clinical testing.
Expertise Areas
- Orthopedic joint preservation
- Cartilage regeneration and resurfacing
- Clinical trial conduct for implantable devices
- Regulatory strategy for medical devices
Key Technologies
- Regenerative orthopedic implants
- Biomaterial scaffolds for cartilage repair
- Implantable device design for joint resurfacing
- Clinical trial protocols for orthopedic devices
News & Updates
Highly anticipated cartilage repair implant from CytexOrtho receives greenlight to move forward with human clinical trials.
This Bonezone article sheds light on CytexOrtho and other companies in regenerative medicine.
Highly anticipated cartilage repair implant from CytexOrtho receives greenlight to move forward with human clinical trials.
This Bonezone article sheds light on CytexOrtho and other companies in regenerative medicine.